Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1978 1
1979 1
1980 1
1981 3
1982 2
1983 4
1984 2
1987 3
1988 5
1989 4
1990 8
1991 3
1992 2
1993 3
1994 4
1995 1
1996 3
1997 3
1998 5
1999 1
2000 5
2001 6
2002 4
2003 3
2004 4
2005 2
2006 1
2007 2
2008 2
2009 3
2010 3
2012 2
2013 4
2014 1
2015 1
2016 5
2017 2
2018 4
2019 7
2020 6
2021 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Palliative care teaching: Student perspective.
Sabir A, Fairey M, Bayne M. Sabir A, et al. Among authors: bayne m. Med Teach. 2020 Mar;42(3):356. doi: 10.1080/0142159X.2019.1620929. Epub 2019 Jun 7. Med Teach. 2020. PMID: 31170858 No abstract available.
Antibody therapy of lymphoma.
Illidge TM, Bayne MC. Illidge TM, et al. Among authors: bayne mc. Expert Opin Pharmacother. 2001 Jun;2(6):953-61. doi: 10.1517/14656566.2.6.953. Expert Opin Pharmacother. 2001. PMID: 11585011 Review.
GGT test.
DiPalma JA, Bayne MA. DiPalma JA, et al. Among authors: bayne ma. Dig Dis Sci. 1987 Nov;32(11):1325-6. doi: 10.1007/BF01296386. Dig Dis Sci. 1987. PMID: 2889588 No abstract available.
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
Hodak E, Sherman S, Papadavid E, Bagot M, Querfeld C, Quaglino P, Prince HM, Ortiz-Romero PL, Stadler R, Knobler R, Guenova E, Estrach T, Patsatsi A, Leshem YA, Prague-Naveh H, Berti E, Alberti-Violetti S, Cowan R, Jonak C, Nikolaou V, Mitteldorf C, Akilov O, Geskin L, Matin R, Beylot-Barry M, Vakeva L, Sanches JA, Servitje O, Weatherhead S, Wobser M, Yoo J, Bayne M, Bates A, Dunnill G, Marschalko M, Buschots AM, Wehkamp U, Evison F, Hong E, Amitay-Laish I, Stranzenbach R, Vermeer M, Willemze R, Kempf W, Cerroni L, Whittaker S, Kim YH, Scarisbrick JJ; Cutaneous Lymphoma International Consortium (CLIC) institutions. Hodak E, et al. Among authors: bayne m. Br J Dermatol. 2021 Mar;184(3):524-531. doi: 10.1111/bjd.19303. Epub 2020 Sep 10. Br J Dermatol. 2021. PMID: 32574377 Review.
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.
Bricault CA, Yusim K, Seaman MS, Yoon H, Theiler J, Giorgi EE, Wagh K, Theiler M, Hraber P, Macke JP, Kreider EF, Learn GH, Hahn BH, Scheid JF, Kovacs JM, Shields JL, Lavine CL, Ghantous F, Rist M, Bayne MG, Neubauer GH, McMahan K, Peng H, Chéneau C, Jones JJ, Zeng J, Ochsenbauer C, Nkolola JP, Stephenson KE, Chen B, Gnanakaran S, Bonsignori M, Williams LD, Haynes BF, Doria-Rose N, Mascola JR, Montefiori DC, Barouch DH, Korber B. Bricault CA, et al. Among authors: bayne mg. Cell Host Microbe. 2019 Jan 9;25(1):59-72.e8. doi: 10.1016/j.chom.2018.12.001. Cell Host Microbe. 2019. PMID: 30629920 Free PMC article.
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.
Bricault CA, Yusim K, Seaman MS, Yoon H, Theiler J, Giorgi EE, Wagh K, Theiler M, Hraber P, Macke JP, Kreider EF, Learn GH, Hahn BH, Scheid JF, Kovacs JM, Shields JL, Lavine CL, Ghantous F, Rist M, Bayne MG, Neubauer GH, McMahan K, Peng H, Chéneau C, Jones JJ, Zeng J, Ochsenbauer C, Nkolola JP, Stephenson KE, Chen B, Gnanakaran S, Bonsignori M, Williams LD, Haynes BF, Doria-Rose N, Mascola JR, Montefiori DC, Barouch DH, Korber B. Bricault CA, et al. Among authors: bayne mg. Cell Host Microbe. 2019 Aug 14;26(2):296. doi: 10.1016/j.chom.2019.07.016. Cell Host Microbe. 2019. PMID: 31415756 Free PMC article. No abstract available.
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma.
Kolstad A, Illidge T, Bolstad N, Spetalen S, Madsbu U, Stokke C, Blakkisrud J, Løndalen A, O'Rourke N, Beasley M, Jurczak W, Fagerli UM, Kaščák M, Bayne M, Obr A, Dahle J, Rojkjaer L, Pascal V, Holte H. Kolstad A, et al. Among authors: bayne m. Blood Adv. 2020 Sep 8;4(17):4091-4101. doi: 10.1182/bloodadvances.2020002583. Blood Adv. 2020. PMID: 32877524 Free PMC article. Clinical Trial.
120 results